BHK Investment Advisors, LLC - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 154 filers reported holding FIBROGEN INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
BHK Investment Advisors, LLC ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2023$49,725
-78.2%
57,625
-31.9%
0.02%
-76.5%
Q2 2023$228,339
-85.7%
84,570
-0.9%
0.10%
-85.9%
Q1 2023$1,591,698
+13.5%
85,300
-2.6%
0.70%
-11.8%
Q4 2022$1,402,551
+23.2%
87,550
+0.1%
0.79%
+38.2%
Q3 2022$1,138,000
+23.3%
87,4500.0%0.57%
+37.6%
Q2 2022$923,000
+27.0%
87,450
+44.7%
0.42%
+36.5%
Q1 2022$727,000
-14.2%
60,450
+0.7%
0.30%
-9.0%
Q4 2021$847,000
+18.0%
60,050
-14.6%
0.33%
+12.8%
Q3 2021$718,000
-40.2%
70,300
+55.9%
0.30%
-39.6%
Q2 2021$1,201,000
-14.5%
45,100
+19.2%
0.49%
-24.8%
Q1 2021$1,404,000
+0.4%
37,850
+0.4%
0.65%0.0%
Q4 2020$1,398,000
-9.5%
37,700
+0.4%
0.65%
-25.0%
Q3 2020$1,544,000
-0.6%
37,550
-2.1%
0.87%
-5.3%
Q2 2020$1,554,000
+20.1%
38,350
+3.0%
0.92%
-0.3%
Q1 2020$1,294,000
+6.6%
37,250
+31.6%
0.92%
+33.1%
Q4 2019$1,214,000
+22.8%
28,300
+5.8%
0.69%
+21.2%
Q3 2019$989,000
-6.6%
26,750
+14.1%
0.57%
-5.1%
Q2 2019$1,059,000
-3.3%
23,450
+16.4%
0.60%
-9.3%
Q1 2019$1,095,000
+30.7%
20,150
+11.3%
0.66%
+5.4%
Q4 2018$838,000
-8.3%
18,100
+20.3%
0.63%
+2.4%
Q3 2018$914,000
-3.0%
15,0500.0%0.62%
-6.1%
Q2 2018$942,000
+42.3%
15,050
+5.0%
0.66%
+34.2%
Q1 2018$662,000
+1.2%
14,336
+3.9%
0.49%
-11.6%
Q4 2017$654,00013,8000.55%
Other shareholders
FIBROGEN INC shareholders Q2 2022
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 305,784$8,143,0008.63%
Vantage Consulting Group Inc 605,713$16,130,0002.81%
GREAT POINT PARTNERS LLC 500,000$13,315,0002.79%
HHLR ADVISORS, LTD. 3,955,787$105,343,0001.08%
Intercontinental Wealth Advisors, LLC 191,300$5,094,0001.01%
Ikarian Capital, LLC 250,000$6,657,0000.54%
BHK Investment Advisors, LLC 45,100$1,201,0000.49%
Ikarian Capital, LLC 193,800$5,161,0000.42%
Omega Fund Management, LLC 130,646$3,479,0000.39%
Rhenman & Partners Asset Management AB 200,000$5,326,0000.36%
View complete list of FIBROGEN INC shareholders